60度制药公司的禁闭协议于2025年10月15日到期,允许内幕出售股票。 A lock-up agreement for 60 Degrees Pharmaceuticals expires on Oct. 15, 2025, allowing insiders to sell shares.

60度制药公司限制出售某些股票、许可证和股票选择权的扣押协议于2025年10月15日到期。 A lock-up agreement restricting the sale of certain shares, warrants, and stock options in 60 Degrees Pharmaceuticals, Inc. expires on October 15, 2025. 从2025年7月16日开始的91天时期适用于拥有该公司5%或5%以上共同股票的经理、董事和股东。 The 91-day period, beginning July 16, 2025, applies to executives, directors, and shareholders owning 5% or more of the company’s common stock. 该协议是最近发行的证券的一部分,旨在稳定股票价格,防止内幕人员在提供证券后立即出售其股份。 The agreement, part of a recent securities offering, aims to stabilize the stock price by preventing insiders from selling their holdings immediately after the offering.